Skip to main content
Log in

VEGF-R1 as a Potential Molecular Target for Anticancer Therapy

  • Biochemistry, Biophysics, and Molecular Biology
  • Published:
Doklady Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

The possibility of using VEGF-R1 receptor for targeted therapy in oncology was investigated. Using the approach to measuring the protein content in intact nuclei of cells, which was developed by us, we showed the presence of this receptor in the nuclei of tumor, but not normal cells. A direct correlation between the level of VEGF-R1 expression in the nucleus and the degree of malignancy of tumor cells, indicating the prognostic value of this parameter, was found. The mechanisms of the functioning of this receptor and the pathways of inhibiting its activity are discussed, and the validity of the selection of VEGF-R1 as a molecular target for anticancer therapy is conformed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fan, F., Wey, J.S., McCarty, M.F., et al., Oncogen, 2005, vol. 24, pp. 2647–2653.

    Article  CAS  Google Scholar 

  2. Wey, J.S., Fan, F., Gray, M.J., et al., Cancer, 2005, vol. 104, pp. 427–438.

    Article  CAS  PubMed  Google Scholar 

  3. Lee, T.-H., Seng, S., Sekine, M., et al., PLoS Medicine, 2007, vol. 4, no. 6, pp. 1001–1016.

    Article  Google Scholar 

  4. Bhattacharya, R., Ye, X.C., Wang, R., et al., Cancer Res., 2016, vol. 76, no. 10, pp. 3014–3024. doi: 10.1158/0008-5472.CAN-15-1605

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Tyrsina, E.G., Nikulitskii, S.I., Inshakov, A.N., and Ryabaya, O.O., Onkoginekologiya, 2016, no. 2, pp. 13–21.

    Google Scholar 

  6. Nikulitskii, S.I., Tyrsina, E.G., Inshakov, A.N., and Borovkova, N.B., Ross. Bioterapevt. Zh., 2016, no. 2, pp. 75–80.

    Google Scholar 

  7. Szabo, E., Schneider, H., Seystahl, K., et al., Neuro Oncol., 2016, no. 9, pp. 1242–1252. doi: 10.1093/neuonc/now043

    Article  Google Scholar 

  8. Vincent, L., Jin, D.K., Karajannis, M.A., et al., Cancer Res., 2005, vol. 65, pp. 3185–3192.

    Article  CAS  PubMed  Google Scholar 

  9. Owen, L.A., Uehara, H., Cahoon, J., et al., PLoS ONE, 2013, vol. 7, no. 3, p. e33576.

    Article  Google Scholar 

  10. Broers, J.L.V. and Ramaekers, F.C.S., Adv. Exp. Med. Biol., 2014, vol. 773, pp. 27–48. doi 10.1007/978-1-4899-8032-8_2.2. PMID:24563342

    Article  CAS  PubMed  Google Scholar 

  11. Chen, M.-K. and Hung, M.-C., Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases, FEBS J., 2015, vol. 282, no. 19, pp. 3693–3721. doi 10.1111/febs.13342

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. G. Tyrsina.

Additional information

Original Russian Text © E.G. Tyrsina, S.I. Nikulitskiy, A.N. Inshakov, O.O. Ryabaya, 2018, published in Doklady Akademii Nauk, 2018, Vol. 478, No. 2, pp. 236–239.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tyrsina, E.G., Nikulitskiy, S.I., Inshakov, A.N. et al. VEGF-R1 as a Potential Molecular Target for Anticancer Therapy. Dokl Biochem Biophys 478, 18–20 (2018). https://doi.org/10.1134/S1607672918010052

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1607672918010052

Navigation